Comment on ''the effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria'': reply from authors.

Comment on ''the effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria'': reply from authors. Cutan Ocul Toxicol. 2020 Mar 17;:1-3 Authors: Acer E, Kaya Erdoğan H, Yüksel Çanakçı N, Saracoğlu ZN Abstract We read Cosansu's commentary entitled '' Effectiveness of the new inflammatory parameters in patients with chronic spontaneous urticaria'' to our study with great interest. The author remarked that a limited number patients had C-reactive Protein levels and it was not specified whether there were any other drugs used by the patients and no information was given about the severity of the disease in our study. PMID: 32183543 [PubMed - as supplied by publisher]
Source: Cutaneous and Ocular Toxicology - Category: Toxicology Authors: Tags: Cutan Ocul Toxicol Source Type: research